The transaction covers the company’s ophthalmic division across India and select international territories, including Benin, Burkina Faso, Ivory Coast, Mali, Niger, Mauritania, Senegal, Cameroon, Congo, Gabon, Kenya, Botswana, Tanzania, Zambia, Zimbabwe and Namibia. Shares of Indoco Remedies Ltd ended at ₹209.05, down by ₹0.15, or 0.072%, on the BSE today, April 30.
